Global Health Ltd share price logo

Global Health Ltd Share Price

(MEDANTA)

₹1198.31.28%

as on 04:01PM, 28 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Medanta Performance

  • Day's Low

    Day's High

    ₹1,189
    Day's Price Range
    ₹1,229.5
  • 52 Week's Low

    52 Week's High

    ₹935.5
    52-Week Price Range
    ₹1,511
1 Month Return+ 5.58 %
3 Month Return+ 12.57 %
1 Year Return-8.12 %
Previous Close₹1,213.85
Open₹1,229.45
Volume2.64L
Upper Circuit₹1,456.60
Lower Circuit₹971.10
Market Cap₹32,602.48Cr

Medanta Fundamentals

P/E Ratio

64.26

PEG Ratio

31.35

Market Cap

₹32,602.48 Cr

P/B Ratio

12.48

EPS

12.16

Dividend Yield

0

Sector

Healthcare

ROE

13.52

Medanta Analyst Rating

based on 15 analysts

BUY

66.67%

Buy

20.00%

Hold

13.33%

Sell

Based on 15 analysts offering long term price targets for Medanta. An average target of ₹1271.8

Source: S&P Global Market Intelligence

Medanta Share analysis

Medanta price forecast by 15 analysts

Upside of4.77%

High

₹1470

Target

₹1271.80

Low

₹860

Medanta target price ₹1271.8, a slight upside of 4.77% compared to current price of ₹1198.3. According to 15 analysts rating.

Source: S&P Global Market Intelligence

Key events for Global Health Ltd

  • Axis Securities Issues Buy Call on Global Health - 28 Mar, 2025

    Axis Securities recommends a buy on Global Health with a target price of Rs 1,390. The company reported a net profit of Rs 142.86 crore and anticipates growth from the upcoming Noida hospital. Management is optimistic about revenue drivers and operational excellence.
  • Global Health Ltd Announces Trading Window Closure - 27 Mar, 2025

    Global Health Limited has announced the closure of its trading window from April 1, 2025, until 48 hours after its Q4 financial results. This standard procedure aims to prevent insider trading and ensure transparency.
  • Crisil Reaffirms Global Health's Ratings with Positive Outlook - 19 Mar, 2025

    Crisil Ratings reaffirmed Global Health's AA-/A1+ rating with a positive outlook, citing 12% revenue growth and strong financial metrics. Despite some profitability moderation, the company expects continued growth supported by bed additions and improved occupancy levels.
  • Global Health Receives Credit Rating Affirmation - 18 Mar, 2025

    Global Health has received affirmation in credit ratings from CRISIL Ratings following the merger of Medanta Holdings. The long-term rating is CRISIL AA-/Positive, and the short-term rating is CRISIL A1+, with total bank loan facilities rated at Rs. 1500 crore.
  • Global Health Ltd Shows Potential for Upsurge - 05 Mar, 2025

    Global Health Ltd (MEDANTA) is showing early signs of capital inflow, with its stock reaching a 6-month high amidst broader market lows. Analysts suggest a potential 9-12% upward movement due to sustained price action and higher low formations.
  • JM Financial Issues Buy Call on Global Health - 28 Feb, 2025

    JM Financial has a buy recommendation for Global Health with a target price of Rs 1,465, citing strong revenue growth and expansion plans. The company is expected to achieve a 19% CAGR in revenue over the next two years, supported by increased bed capacity and margin improvements.
  • Bullish Outlook for Global Health Ltd Stock - 27 Feb, 2025

    A buy recommendation for Global Health Ltd (MEDANTA) suggests entering at ₹1,212, targeting ₹1,288-1,310, with a stop loss at ₹1,168. The RSI indicates potential upside.

Insights on Global Health Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 43.65% to 43.98% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, MEDANTA stock has moved up by 12.6%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 106.29 Cr → 142.91 Cr (in ₹), with an average increase of 13.6% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 12.20% to 12.47% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 59.9% return, outperforming this stock by 68.0%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 9.59% to 9.00% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 33.04% to 33.03% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 974.77 Cr → 959.46 Cr (in ₹), with an average decrease of 1.6% per quarter

Medanta Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹836.45Cr (-)₹808.63Cr (↓3.33%)₹861.08Cr (↑6.49%)₹956.56Cr (↑11.09%)₹943.44Cr (↓1.37%)
Net Income₹123.54Cr (-)₹127.35Cr (↑3.08%)₹106.26Cr (↓16.56%)₹130.82Cr (↑23.11%)₹142.86Cr (↑9.20%)
Net Profit Margin14.77% (-)15.75% (↑6.64%)12.34% (↓21.65%)13.68% (↑10.86%)15.14% (↑10.67%)
Value in ₹ crore
Details2021202220232024
Total Assets₹2,047.10Cr (-)₹2,401.86Cr (↑17.33%)₹3,249.12Cr (↑35.28%)₹3,595.03Cr (↑10.65%)
Total Liabilities₹563.46Cr (-)₹662.11Cr (↑17.51%)₹760.26Cr (↑14.82%)₹746.23Cr (↓1.85%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹192.56Cr (-)₹200.88Cr (↑4.32%)₹235.40Cr (↑17.18%)₹430.53Cr (↑82.89%)₹340.64Cr (↓20.88%)

Medanta Index Inclusions

S&P BSE SmallCap Select

₹6,954.89

0.04 (2.86%)

S&P BSE 150 MidCap

₹14,418.50

-0.56 (-81.33%)

BSE Healthcare

₹41,421.50

-0.12 (-48.19%)

Nifty Midcap 150

₹19,120.35

-0.29 (-55.05%)

Nifty 500

₹21,339.55

-0.32 (-68.4%)

Nifty LargeMidcap 250

₹14,821.10

-0.33 (-48.35%)

Nifty MidSmallcap 400

₹17,677.95

-0.2 (-36.15%)

BSE 500

₹33,579.22

-0.39 (-132.39%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

S&P BSE 250 LargeMidCap

₹10,029.73

-0.39 (-38.93%)

S&P BSE 400 MidSmallCap

₹10,772.07

-0.52 (-56.71%)

BSE Small-Cap

₹46,638.13

-0.35 (-165.52%)

Medanta Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
33.03%
-0.01
Foreign Institutions
12.47%
2.21
Mutual Funds
9%
-6.13
Retail Investors
43.98%
0.78
Others
1.51%
-1.04

Medanta Key Indicators

Details2023
Earning Per Share (₹)12.16
Details20202021202220232024
Return On Equity %7.73.9913.5712.4513.52
Details20192020202120222023
Return On Assets %2.921.861.418.1710.04
Details2023
Book Value Per Share (₹)90.54

Medanta Valuation

Medanta in the last 5 years

  • Overview

  • Trends

Lowest (37.92x)

April 6, 2023

Today (64.26x)

March 27, 2025

Industry (97.97x)

March 27, 2025

Highest (88.30x)

February 23, 2024

LowHigh

Medanta Earnings and Dividends

  • Global Health Ltd Earnings Results

    Global Health Ltd’s net profit jumped 15.59% since last year same period to ₹142.91Cr in the Q3 2024-2025. On a quarterly growth basis, Global Health Ltd has generated 9.23% jump in its net profits since last 3-months.

    Read More about Earnings Results

Medanta Technicals Summary

Bearish

Neutral

Bullish

Neutral

Global Health Ltd is currently in a Neutral trading position according to technical analysis indicators.

Medanta Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹32,602.48 Cr38.46%0.55₹326 Cr₹2,694 Cr
BUY₹34,197.74 Cr128.35%0.69₹789 Cr₹5,018 Cr
BUY₹50,718.09 Cr85.71%0.54₹645 Cr₹7,175 Cr

About Medanta

Global Health Limited (quickly known as GHL) was established on August 13th 2004, and converted to a public limited company on July 31st 2021. It is a renowned private multispeciality tertiary care provider operating in the North and East regions of India, which provides healthcare services in over 30 medical specialties. Dr. Naresh Trehan founded GHL, with current 5 hospitals operational in its network. On November 2009, the company opened its flagship hospital in Gurugram with 200 installed beds and 50 doctors across key specialties, and its Patna hospital currently has 228 installed beds and employs over 125 doctors, designed to accommodate 500 beds. In January 2021, GHL decided to raise capital by
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.

Revenue: ₹943.44Cr as on December 2024 (Q4 24)
Net Profit: ₹142.86Cr as on December 2024 (Q4 24)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
OrganisationMedanta
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Global Health Ltd

What is Global Health Ltd price today?

Global Health Ltd share price today stands at ₹1198.3, Open: ₹1229.45, Previous Close: ₹1213.85, High: ₹1229.5, Low: ₹1189, 52 Week High: ₹1511, 52 Week Low: ₹935.5.

How to Buy Global Health Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Global Health Ltd shares

What are today's traded volumes of Global Health Ltd?

Today's traded volume of Global Health Ltd(MEDANTA) is 2.64L.

What is today's market capitalisation of Global Health Ltd?

Today's market capitalisation of Global Health Ltd(MEDANTA) is ₹32602.48Cr.

What is the 52 Week High and Low Range of Global Health Ltd?

Global Health Ltd (MEDANTA)
Price
52 Week High
₹1511
52 Week Low
₹935.5

How much percentage Global Health Ltd is down from its 52 Week High?

Global Health Ltd (MEDANTA) share price is ₹1198.3. It is down -20.69% from its 52 Week High price of ₹1511

How much percentage Global Health Ltd is up from its 52 Week low?

Global Health Ltd (MEDANTA) share price is ₹1198.3. It is up 28.09% from its 52 Week Low price of ₹935.5